A powerful o-quinone dimethide strategy for intermolecular Diels-Alder cycloadditions

Journal of the American Chemical Society

Volumn 122, Issue 4, 2000, Pages 571-575

  Allen, John G ^a   Hentemann, Martin F ^a   Danishefsky, Samuel J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; IDARUBICIN; IDARUBICIN DERIVATIVE; NAPHTHALENE DERIVATIVE; QUINONE DERIVATIVE;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; DRUG SYNTHESIS; OXIDATION; REACTION ANALYSIS; STEREOCHEMISTRY; TEMPERATURE DEPENDENCE;

EID: 0033952620     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja993627u     Document Type: Article

References (73)

1. Oppolzer, W. Intramolecular Diels-Alder Reactions. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1991; Vol. 5, p 315.
2. (a) Danishefsky, S. J.; Kitahara, T. J. Am. Chem. Soc. 1974, 96, 7807.
3. (b) Danishefsky, S. J.; Kitahara, T. J. Org. Chem. 1975, 40, 538.
4. (a) Michellys, P.-Y.; Pellissier, H.; Santelli, M. Org. Prep. Proc. Int. 1996, 28, 545.
5. (b) Funk, R. L.; Vollhardt, K. P. C. Chem. Soc. Rev. 1980, 9, 41.
6. (c) McCullough, J. J. Acc. Chem. Res. 1980, 13, 270.
7. (d) Charlton, J. L.; Alauddin, M. M. Tetrahedron 1987, 43, 2873.
8. (a) Han, B.-H.; Boudjouk, P. J. Org. Chem. 1982, 47, 751.
9. (b) Rubottom, G. M.; Wey, J. E. Synth. Commun. 1984, 14, 507.
10. (c) Inaba, S.; Wehmeyer, R. M.; Forkner, M. W.; Rieke, R. D. J. Org. Chem. 1988, 53, 339.
11. (d) Schiess, P. Thermochim. Acta 1987, 112, 31.
12. (e) See also: Troll, T.; Schmid, K. Tetrahedron Lett. 1984, 25, 2981.
13. (a) Cava, M. P.; Deana, A. A. J. Am. Chem. Soc. 1959, 81, 4266.
14. (b) Jung, F.; Molin, M.; Van Den Dlzen, R.; Durst, T. J. Am. Chem. Soc. 1974, 96, 935.
15. (c) Durst, T.; Tetreault-Ryan, L. Tetrahedron Lett. 1978, 2353.
16. (d) Charlton, J. L. Can. J. Chem. 1985, 64, 723.
17. (a) Jung, M. E.; Lowe, J. A. J. Org. Chem. 1977, 42, 2371.
18. (b) Krohn, K.; Rieger, H.; Broser, E.; Schiess, P.; Chen, S.; Strubin, T. Liebigs Ann. Chem. 1988, 943.
19. (c) Krohn, K. Angew. Chem., Int. Ed. Engl. 1986, 25, 790.
20. (d) Kessar, S. V.; Mankotia, A. K. S.; Agnihotri, K. R. J. Chem. Soc., Chem. Commun. 1993, 598.
21. (e) Sammes, P. G. Tetrahedron 1976, 32, 405.
22. (f) Coll, G.; Costa, A.; Deyá, P. M.; Flexas, F.; Rotger, C.; Saá, J. M. J. Org. Chem. 1992, 57, 6222.
23. (a) Jensen, F.; Coleman, W. E. J. Am. Chem. Soc. 1958, 80, 6149.
24. (b) Wong, H. N. C.; Lan, K.-L.; Tam, D. F. Top. Curr. Chem. 1986, 133, 124-130.
25. (c) Arnold, B. J.; Sammes, P. G.; Wallace, T. W. J. Chem. Soc., Perkin Trans. 1 1974, 401.
26. (d) Macdonald, D. I.; Durst, T. J. Org. Chem. 1986, 51, 4750.
27. (e) Franck, R. W.; John, T. V.; Olejniczak, K. J. Am. Chem. Soc. 1982, 104, 1106.
28. (f) Jung, M. E.; Lam, P. Y.-S.; Mansuri, M.; Speltz, L. M. J. Org. Chem. 1985, 50, 1087.
29. (a) LaDuranty, J.; Lepage, L.; Lepage, Y. Can. J. Chem. 1980, 1161.
30. (b) Amaro, A.; Carreno, M. C.; Farina, F. Tetrahedron Lett. 1979, 3983.
31. (c) Moss, R. J.; Rickborn, B. J. Org. Chem. 1984, 49, 3694.
32. (d) Kametani, T.; Toya, T.; Ueda, K.; Tsubuki, M.; Honda, T. J. Chem. Soc., Perkin Trans. 1 1988, 2433.
33. (a) Oppolzer, W. Synthesis 1978, 793.
34. (b) Kametani, T. Pure Appl. Chem. 1979, 51, 747.
35. (c) Kametani, T.; Nemoto, H. Tetrahedron 1981, 37, 3.
36. (d) Magnus, P.; Gallagher, T.; Brown, P.; Pappalardo, P. Acc. Chem. Res. 1984, 17, 35.
37. (e) Ito, Y.; Nakatsuka, M.; Saegusa, T. J. Am. Chem. Soc. 1982, 104, 7609.
38. (f) Oppolzer, W. Heterocycles 1980, 14, 1615.
39. (g) Nemoto, H.; Fukumoto, K. Tetrahedron 1998, 54, 5425.
40. (a) Dolbier, W. R.; Koroniak, H.; Houk, K. N.; Sheu, C. Acc. Chem. Res. 1996, 29, 471.
41. (b) KirMSe, W.; Rondan, N. G.; Houk, K. N. J. Am. Chem. Soc. 1984, 106, 7989.
42. (c) Niwayama, S.; Kallel, E. A.; Sheu, C.; Houk, K. M. J. Org. Chem. 1996, 61, 2517.
43. (d) Niwayama, S.; Kallel, E. A.; Spellmeyer, D. C.; Sheu, C.; Houk, K. M. J. Org. Chem. 1996, 61, 2813.
44. (a) Rudolf, K.; Spellmeyer, D. C.; Houk, K. N. J. Org. Chem. 1987, 52, 3708.
45. (b) Houk, K. N.; Spellmeyer, D. C.; Jefford, C. W.; Rimbault, C. G.; Wang, Y.; Miller, R. D. J. Org. Chem. 1988, 53, 2125.
46. (c) Nakamura, K.; Houk, K. N. J. Org. Chem. 1995, 60, 686.
47. trans-Diacyloxy-substituted benzocyclobutenes of type 3 give Diels-Alder products with 42 at 80°C. Elaboration into the naphthoquinone was not possible, and in practice, thermal elimination of the diacetoxy groups gave the corresponding anthracene: (a) Hassall, C. H.; Broadhurst, M. J.; Thomas, G. J. J. Chem. Soc., Perkin Trans. 1 1982, 2239. (b) Broadhurst, M. J.; Hassall, C. H.; Thomas, G. J. Tetrahedron 1984, 40, 4649.
48. trans-Diacyloxy-substituted benzocyclobutenes of type 3 give Diels-Alder products with 42 at 80°C. Elaboration into the naphthoquinone was not possible, and in practice, thermal elimination of the diacetoxy groups gave the corresponding anthracene: (a) Hassall, C. H.; Broadhurst, M. J.; Thomas, G. J. J. Chem. Soc., Perkin Trans. 1 1982, 2239. (b) Broadhurst, M. J.; Hassall, C. H.; Thomas, G. J. Tetrahedron 1984, 40, 4649.
49. trans-Dimethoxybenzocyclobutenes of type 3 give Diels-Alder products with maleic anhydride: Arnold, B. J.; Sammes, P. G.; Wallace, T. W. J. Chem. Soc., Perkin Trans. 1 1974, 415.
50. (a) Liebeskind, L. S.; Lescosky, L. J.; McSwain, C. M., Jr. J. Org. Chem. 1989, 54, 1435.
51. (b) Dürr, H.; Nickels, H. J. Org. Chem. 1980, 45, 973.
52. (c) Abou-Teim, O.; Goodland, M. C.; McOmie, F. W. J. Chem. Soc., Perkin Trans. 1 1983, 2659.
53. (d) Liebeskind, L. S.; South, M. S. J. Org. Chem. 1982, 47, 3815.
54. Silyloxy-substituted benzocyclobutenes have also been prepared by Suzuki: (e) Hosoya, T.; Hasegawa, T.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 1995, 36, 3377. (f) Hosoya, T.; Hasegawa, T.; Kuriyama, Y.; Matsumoto, T.; Suzuki, K. Synlett 1995, 177. (g) Matsumoto, T.; Hamura, T.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 1997, 38, 8985.
55. Silyloxy-substituted benzocyclobutenes have also been prepared by Suzuki: (e) Hosoya, T.; Hasegawa, T.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 1995, 36, 3377. (f) Hosoya, T.; Hasegawa, T.; Kuriyama, Y.; Matsumoto, T.; Suzuki, K. Synlett 1995, 177. (g) Matsumoto, T.; Hamura, T.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 1997, 38, 8985.
56. Silyloxy-substituted benzocyclobutenes have also been prepared by Suzuki: (e) Hosoya, T.; Hasegawa, T.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 1995, 36, 3377. (f) Hosoya, T.; Hasegawa, T.; Kuriyama, Y.; Matsumoto, T.; Suzuki, K. Synlett 1995, 177. (g) Matsumoto, T.; Hamura, T.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 1997, 38, 8985.
57. Bis(trimethylsilyloxy) derivatives 11 and 33 were obtained in 4:1-6:1 trans/cis ratios. The bis(tert-butyldimethylsilyloxy) derivatives 12 and 27 were obtained in 6:1-9:1 trans/cis ratios. The difference was possibly due to partial decompostion of the trans isomer during preparation of 11 and 33.
58. (a) Fringuelli, F.; Taticchi, A.; Wenkert, E. Org. Prep. Proc. Int. 1990, 22, 131.
59. (b) Bartlett, P. D.; Woods, G. F. J. Am. Chem. Soc. 1940, 62, 2933.
60. (c) Friguelli, F.; Pizzo, F.; Taticchi, A.; Halls, T. D. J.; Wenkert, E. J. Org. Chem. 1982, 47, 5057.
61. Relative configuration of the adducts were determined by 2-D and NOE NMR experiments. All product ratios were determined by integration in the NMR spectra.
62. 4: (a) Jung, M. E. J. Org. Chem. 1976, 41, 1479. See also: (b) Muzart, J. Synthesis 1993, 11.
63. 4: (a) Jung, M. E. J. Org. Chem. 1976, 41, 1479. See also: (b) Muzart, J. Synthesis 1993, 11.
64. (a) Paterson, I.; Cowden, C. J.; Rahn, V.; Woodrow, M. D. Synlett 1998, 915.
65. (b) Piva, O.; Amougay, A.; Pete, J. Tetrahedron Lett. 1991, 32, 3993.
66. (c) Jung, M. E.; Pan, Y.-G.; Rathke, M. W.; Sullivan, D. F.; Woodbury, R. P. J. Org. Chem. 1977, 42, 3961.
67. Compound 28 was obtained as a 4:3 mixture of endo and exo diastereomers.
68. (a) Bosshard, D.; Fumagalli, S.; Good, R.; Treub, W.; Philipsborn, W. V.; Eugster, C. H. Helv. Chim. Acta 1964, 47, 769.
69. (b) Uno, H. J. Org. Chem. 1986, 51, 350.
70. Kessler, H.; Müller, A. Liebigs Ann. Chem. 1986, 1687.
71. Idarubicin (Idamycin) was approved in 1990 for use in the United States for treatment of acute nonlymphocytic and lymphoblastic leukemia. It has been shown to have superior therapeutic efficacy and reduced cardiotoxicity and to provide longer duration of survival compared to Daunorubicin: (a) Hollingshead, L. M.; Faulds, D. Drugs 1991, 42, 690. (b) Cersosimo, R. J. Clin. Pharm. 1992, 11, 152. Idarubicin is produced, with some difficulty, by semisynthesis from Daunomycin: Penco, S. Chim. Ind. Milan 1993, 75, 369; EP 0 337 665 B1.
72. Idarubicin (Idamycin) was approved in 1990 for use in the United States for treatment of acute nonlymphocytic and lymphoblastic leukemia. It has been shown to have superior therapeutic efficacy and reduced cardiotoxicity and to provide longer duration of survival compared to Daunorubicin: (a) Hollingshead, L. M.; Faulds, D. Drugs 1991, 42, 690. (b) Cersosimo, R. J. Clin. Pharm. 1992, 11, 152. Idarubicin is produced, with some difficulty, by semisynthesis from Daunomycin: Penco, S. Chim. Ind. Milan 1993, 75, 369; EP 0 337 665 B1.
73. Idarubicin (Idamycin) was approved in 1990 for use in the United States for treatment of acute nonlymphocytic and lymphoblastic leukemia. It has been shown to have superior therapeutic efficacy and reduced cardiotoxicity and to provide longer duration of survival compared to Daunorubicin: (a) Hollingshead, L. M.; Faulds, D. Drugs 1991, 42, 690. (b) Cersosimo, R. J. Clin. Pharm. 1992, 11, 152. Idarubicin is produced, with some difficulty, by semisynthesis from Daunomycin: Penco, S. Chim. Ind. Milan 1993, 75, 369; EP 0 337 665 B1.